News

Emergency Use Authorization for the First COVID Vaccine


As expected, the U.S. Food and Drug Administration (FDA) followed its independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation to approve an emergency use authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine, BNT162b2, on Dec. 11, 2020. Although workers’ compensation does not typically provide coverage for vaccinations, please be aware that the Centers for …

Shanea McKinney to Present at Upcoming RIMS Chapter Events


myMatrixx Clinical Account Executive Shanea McKinney is a regular speaker for RIMS, the risk management society, and their Professional Exchange of Risk Knowledge, or PERK, program. In the coming weeks she will be delivering two of her accepted presentations to RIMS chapters virtually in Oregon and Tampa Bay.  First, on December 17th, Shanea will be …

Phil Walls Discusses the History of Fentanyl in New NWCDC CompTalks Video


myMatrixx Chief Clinical Officer, Phil Walls, was once again featured in the National Workers Compensation and Disability Conference (NWCDC) CompTalks series. This is an ongoing part of the 2020 virtual NWCDC and was envisioned to showcase thought leaders from across the industry and the topics they’re passionate about. Phil’s newest presentation is “Risky Business: the …

Dr. Michael Nguyen Discusses Early Behavioral Health Engagement on WorkersCompensation.com


myMatrixx Director of Clinical Pharmacy, Michael Nguyen PharmD, has a new article on WorkersCompensation.com’s regular Expert’s View feature discussing the importance of early engagement in behavioral health for injured workers. In the piece, “Why myMatrixx Believes Early Engagement in Behavioral Health Leads to Better Workers’ Comp Outcomes,” Dr. Nguyen shares evidence from recent studies on …